News
Johns Hopkins Scientists Grew Miniature Brains From Alzheimer's Patients' Cells to Test How Different People Respond to the Same Drug
Johns Hopkins researchers grew Alzheimer's patients' brain organoids and found dramatic individual differences in drug response, a potential step toward personalized treatment.
→
Rapamycin: Where Science Ends and the Promises Begin
Rapamycin has emerged as a leading compound in longevity research, with decades of evidence showing it targets key aging pathways. But experts say important questions about long-term safety, dosing, and benefits for healthy people remain unanswered.
→
A First-of-Its-Kind Global Study Links Prolonged Heat Waves to Sharply Higher Mental Health Hospitalizations
A 2026 Nature Health study of 2.6 million hospitalizations found that sustained heat waves are linked to significantly higher mental health hospitalizations across four countries.
→
